Factors associated with antihypertensive drug compliance in 83 884 Chinese patients: A cohort study

Journal of Epidemiology and Community Health

Volumn 64, Issue 10, 2010, Pages 895-901

  Wong, M C S ^a   Jiang, J Y ^a   Griffiths, S M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE CLASS; COHORT ANALYSIS; COMPLIANCE; DRUG; ETHNIC GROUP; HEALTH CARE; HEALTH MONITORING; HEALTH WORKER; HYPERTENSION; MEDICINE; PUBLIC HEALTH; REGRESSION ANALYSIS; RISK FACTOR;

ARTICLE; ATTITUDE TO HEALTH; CHINA; COHORT ANALYSIS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HONG KONG; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RISK; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS;

ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; CHINA; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HONG KONG; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); SOCIOECONOMIC FACTORS; STATE MEDICINE;

CHINA; HONG KONG;

EID: 77957273994     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.091603     Document Type: Article

References (46)

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223
2. World Health Report. 2002: Reducing risks. Promoting healthy life. Geneva, Switzerland: World Health Organization, 2002.
3. HDFP Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2571
4. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-3264
5. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17.
6. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa, and Asia. J Hum Hypertens 2004;18:545-551
7. Stephenson J. Noncompliance may cause half of antihypertensive drug "failures". JAMA 1999;282:313-314
8. Burnier M, Schneider MP, Chiolero A, et al. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001;19:335-341
9. van Wijk BLG, Shrank WH, Klungel OH, et al. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens 2008;26:145-153
10. Setaro JF, Black HR. Refractory hypertension. N Engl J Med 1992;327:543-547
11. Osterberg L, Blaschke T. Drug therapy: adherence to medication. N Engl J Med 2005;353:487-497
12. Rodgers PT, Ruffin DM. Medication nonadherence: Part IIda pilot study in patients with congestive heart failure. Manag Care Interface 1998;11:67-69
13. Van Wijk BL, Klungel OH, Heerdink ER, et al. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiol Drug Saf 2006;15:587-593
14. Jokisalo E, Kumpusalo E, Enlund H, et al. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens 2002;16:577-583
15. Taira DA, Gelber RP, Davis J, et al. Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health 2007;12:265-281
16. Shaw E, Anderson JG, Maloney M, et al. Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm 1995;30:201-3, 206-7
17. Wong MCS. Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study. J Hum Hypertens 2008;22:435-437
18. Lowry KP, Dudley TK, Oddone EZ, et al. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 2005;39:1198-1203
19. Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health 1996;86:1805-1808
20. Hospital Authority. HA and Clinical Research - Support, Output and Direction. http://www.ha.org.hk/ho/research-ethics/msdc-p181.pdf (accessed Jul 2010).
21. Wong MCS, Jiang Y, Tang JL, et al. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004e-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res 2008;8:138.
22. Population by-census, 2006, Hong Kong Special Administrative Region, China. http:// www.bycensus2006.gov.hk/en/index.htm (accessed 10 Jul 2009).
23. Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006;47:1039-1048
24. Li WW, Stewart AL, Stotts NA, et al. Cultural factors and medication compliance in Chinese immigrants who are taking antihypertensive medications: instrument development. J Nurs Meas 2005;13:231-252
25. Lee JY, Kusek JW, Greene PG, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996;9:719-725
26. Mallion JM, Baguet JP, Siche JP, et al. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens 1998;16:S75-9.
27. Vincze G, Barner JC, Bohman T, et al. Use of antihypertensive medications among United States veterans newly diagnosed with hypertension. Curr Med Res Opin 2008;24:795-805.
28. Wannemacher AJ, Schepers GP, Townsend KA. Antihypertensive medication compliance in a Veterans Affairs healthcare system. Ann Pharmacother 2002;36:986-991
29. Wetzels GEC, Nelemans P, Schouten JS, et al. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004;22:1849-1855
30. Gerth WC. Compliance and persistence with newer antihypertensive agents. Curr Hypertens Rep 2002;4:424-433
31. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J 2005;149:785-794
32. Carter BL. Adherence, quality of life, cost effectiveness, and the role of the pharmacist. In: Lip GYH, Hall JE, eds. Comprehensive hypertension. Philadephia, USA: Mosby, 2007:1119-1127
33. Burke TA, Sturkenboom MC, Lu SE, et al. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006;24:1193-1200
34. Banta JE, Haskard KB, Haviland MG, et al. Mental health, binge drinking, and antihypertension medication adherence. Am J Health Behav 2009;33:158-171
35. Shaya FT, Du D, Gbarayor CM, et al. Predictors of compliance with antihypertensive therapy in a high-risk Medicaid population. J Natl Med Assoc 2009;101:34-39
36. Cheung BMY, Wong YL, Lau CP. Queen Mary Utilization of Antihypertensive Drugs Study: side effects of antihypertensive drugs. J Clin Pharm Ther 2005;30:391-399
37. Flack JM, Novikov SV, Ferrario CM. Benefits of adherence to antihypertensive drug therapy. Eur Heart J 1996;17:16-20.
38. Charney B. Gender, race, and genetic issues in cardiovascular pharmacotherapeutics. In: Frishman WH, ed. Cardiovascular pharmacotherapeutics. New York: McGraw Hill, 1997:1347-1361
39. Hóer A, Gothe H, Khan ZM, et al. Persistence and adherence with antihypertensive drug therapy in a German sickness fund population. J Hum Hypertens 2007;21:744-746
40. Li WW, Stotts NA, Froelicher ES. Compliance with antihypertensive medication in Chinese immigrants: cultural specific issues and theoretical application. Res Theory Nurs Pract 2007;21:236-254
41. Kaplan NM, Flynn JT. Kaplan's clinical hypertension. 9th edn. Philadelphia: Lippincott Williams and Wilkins, 2006.
42. Canzanello VJ, Jensen PL, Schwartz LL, et al. Improved blood pressure control with a physician-nurse team and home blood pressure measurement. Mayo Clin Proc 2005;80:31-36
43. Bautista LE. Predictors of persistence with antihypertensive therapy: results from the NHANES. Am J Hypertens 2008;21:183-188
44. Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005;23:2093-2100
45. Wong MCS, Jiang JY, Lam A, et al. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens 2008;22:714-716
46. Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ 1999;160:31-37